Impact Biomedical Stock Technical Analysis
| IBO Stock | USD 0.47 0.01 2.08% |
As of the 24th of January, Impact BioMedical retains the insignificant Risk Adjusted Performance, standard deviation of 7.33, and Market Risk Adjusted Performance of (0.16). Impact BioMedical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Impact BioMedical Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Impact, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImpactImpact BioMedical's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical's value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical's market value can be influenced by many factors that don't directly affect Impact BioMedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Impact BioMedical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Impact BioMedical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Impact BioMedical.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in Impact BioMedical on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding Impact BioMedical or generate 0.0% return on investment in Impact BioMedical over 90 days. Impact BioMedical is related to or competes with Neurosense Therapeutics, AIM ImmunoTech, Brainstorm Cell, Alaunos Therapeutics, Moolec Science, Cyclerion Therapeutics, and Quoin Pharmaceuticals. Impact BioMedical is entity of United States More
Impact BioMedical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Impact BioMedical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Impact BioMedical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 |
Impact BioMedical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impact BioMedical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Impact BioMedical's standard deviation. In reality, there are many statistical measures that can use Impact BioMedical historical prices to predict the future Impact BioMedical's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.17) |
Impact BioMedical January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.82 | |||
| Coefficient Of Variation | (6,205) | |||
| Standard Deviation | 7.33 | |||
| Variance | 53.75 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 | |||
| Skewness | 4.27 | |||
| Kurtosis | 27.94 |
Impact BioMedical Backtested Returns
Impact BioMedical holds Efficiency (Sharpe) Ratio of -0.0132, which attests that the entity had a -0.0132 % return per unit of risk over the last 3 months. Impact BioMedical exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Impact BioMedical's Standard Deviation of 7.33, market risk adjusted performance of (0.16), and insignificant Risk Adjusted Performance to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.73, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Impact BioMedical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Impact BioMedical is expected to be smaller as well. At this point, Impact BioMedical has a negative expected return of -0.1%. Please make sure to check out Impact BioMedical's potential upside, as well as the relationship between the daily balance of power and price action indicator , to decide if Impact BioMedical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.07 |
Virtually no predictability
Impact BioMedical has virtually no predictability. Overlapping area represents the amount of predictability between Impact BioMedical time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Impact BioMedical price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Impact BioMedical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | 0.01 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Impact BioMedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Impact BioMedical Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Impact BioMedical volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Impact BioMedical Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Impact BioMedical on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Impact BioMedical based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Impact BioMedical price pattern first instead of the macroeconomic environment surrounding Impact BioMedical. By analyzing Impact BioMedical's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Impact BioMedical's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Impact BioMedical specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Days Sales Outstanding | 28.81 | 25.93 | 23.05 | PTB Ratio | 14.22 | 12.79 | 11.38 |
Impact BioMedical January 24, 2026 Technical Indicators
Most technical analysis of Impact help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Impact from various momentum indicators to cycle indicators. When you analyze Impact charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.16) | |||
| Mean Deviation | 3.82 | |||
| Coefficient Of Variation | (6,205) | |||
| Standard Deviation | 7.33 | |||
| Variance | 53.75 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.18) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (0.17) | |||
| Maximum Drawdown | 61.57 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 8.0 | |||
| Skewness | 4.27 | |||
| Kurtosis | 27.94 |
Impact BioMedical January 24, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Impact stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 392.19 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 0.48 | ||
| Day Typical Price | 0.47 | ||
| Price Action Indicator | (0.01) |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Impact BioMedical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in Impact Stock, please use our How to Invest in Impact BioMedical guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Impact BioMedical. If investors know Impact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Impact BioMedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Impact BioMedical is measured differently than its book value, which is the value of Impact that is recorded on the company's balance sheet. Investors also form their own opinion of Impact BioMedical's value that differs from its market value or its book value, called intrinsic value, which is Impact BioMedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Impact BioMedical's market value can be influenced by many factors that don't directly affect Impact BioMedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Impact BioMedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Impact BioMedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Impact BioMedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.